Home » Topics » BioWorld Science

BioWorld Science
RSS

Excellent preclinical results of Repel announced

June 14, 1996

New topical corticosteroids from Hoechst

June 14, 1996

Zeneca reveals prostaglandin antagonists

June 14, 1996

ADIR claims tachykinin antagonists

June 14, 1996

Dopamine D4 receptor ligands discovered by Pfizer

June 7, 1996

La Jolla Cancer Research Foundation claims mammalian trophinin

June 7, 1996

Zomacton, human growth hormone now available in Italy

June 7, 1996

Torii and Asahi Brewery report aldose reductase inhibitors

June 7, 1996

NN-42-1007: First potent and selective hepatic glycogen phosphorylase inhibitor

June 7, 1996

Ansan and Boehringer Inglheim enter apafant agreement

June 7, 1996

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...